Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications challenges economic modeling rare diseases assessment value spinal muscular atrophy
Decision-Analytic Model to Estimate Costs and Outcomes for Additional Screening for Ischemic Stroke Treatment OPPORTUNITY Our client wanted to understand if the costs of adding computed tomography perfusion ( CTP) or magnetic resonance imaging (MRI) to …
… with our clients on projects researching men's health, diseases related to men's health, or complications of … models (cost effectiveness, budget impact) Economic burden of illness studies Epidemiology of disease Global Value Dossiers Health-related quality-of-life analyses …
… treatment features, do you know how much your patient’s value it? Willingness-to-pay (WTP) can be estimated using a …
… M, Paret K. Transcript The Institute for Clinical and Economic Review, or ICER, is an independent organization that evaluates health technologies in the US. ICER’s value assessment framework is similar to frameworks used by …
… Contributed by: Anne Heyes, MBA Vice President, Head of Value & Access, Europe RTI Health Solutions With the EU's … she is seeing product developers respond to Joint Clinical Assessment (JCA) regulation and Medicare price negotiations. … are equipping themselves to address potential challenges they may face in drug development as they move …
… PhD Executive Director, Patient-Centered Outcomes Assessment The devastating effects that Alzheimer’s Disease … Related Services Patient-Centered Outcomes Assessment Staff Members Dana DiBenedetti …
… analyzing the responses to the comprehension questions and modeling respondents who answer incorrectly. Read more about …
… Differences and Similarities of Health Economic Evaluation for Medical Technologies by HTA Bodies … have been evaluated through various health technology assessment (HTA) frameworks around the world. Because … may seem unclear – particularly the requirements for economic evaluations – making planning for submissions …
… to develop and gain market access for products to treat CV diseases and complications arising from treatment of CV … models Disease prevalence Drug utilization studies Economic analyses of clinical trial designs and validations … studies Preparation of HTA submissions Reimbursement and value communication strategies Survey development, evaluation …
… (cost effectiveness, budget impact) Disease prevalence Economic burden of illness studies Literature reviews … evaluation and implementation Therapy adherence studies Value dossiers …